Ottawa, Canada

Eric LaCasse


Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2004-2011

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Eric LaCasse

Introduction

Eric LaCasse is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of six patents to his name, LaCasse has focused on methods and compositions that enhance therapeutic outcomes for patients with proliferative diseases.

Latest Patents

Among his latest patents is a method for treating cancer using IAP antisense oligomer and chemotherapeutic agents. This invention features methods, compositions, and kits designed to treat patients suffering from proliferative diseases. Another significant patent is related to antisense IAP nucleobase oligomers, which hybridize to IAP polynucleotide. This invention provides methods for using these oligomers to enhance apoptosis and treat various proliferative disorders.

Career Highlights

LaCasse has worked with prominent organizations such as Aegera Therapeutics, Inc. and the University of Ottawa. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Daniel McManus and Jon P Durkin. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Eric LaCasse's contributions to cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…